Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Campus sweep: rapid chagas tests could uncover thousands of hidden cases

NCT ID NCT07033325

Diagnosis Sponsor: Mundo Sano Foundation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether offering a rapid diagnostic test for Chagas disease at a university in Argentina can help find undiagnosed infections and connect people to treatment. Participants are students, faculty, and staff aged 18 and older who get a quick finger-prick test during regular campus activities. Those who test positive are referred for confirmatory testing and treatment, with follow-up support by phone. The study also checks how accurate the rapid test is compared to standard lab methods and maps where infections are most common.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Rapid diagnostic test (RDT) for Trypanosoma cruzi infection
What this could lead to
If successful, this approach could make Chagas diagnosis easier and more accessible, helping more people get treated earlier and reducing the disease's spread.
What could go wrong
This is an observational study, not a treatment trial. The rapid test may be less accurate in real-world conditions, and linking people to care after a positive result can be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

2,568 people

The number who actually took part.

Started

Sep 2024

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Salta is a province in northwestern Argentina where Chagas disease remains endemic. While vectorial transmission has declined in recent years due to control efforts, it has not been fully eliminated. Vertical transmission continues to be a major route of infection. Seroprevalence data indicate that 5% of blood donors and 8% of pregnant women in Salta test positive for Trypanosoma cruzi infection. The study population includes incoming students at the Nationional University of Salta (UNSa), across its nine campuses located throughout the province. According to UNSa records, in 2023, around 8,000 students began their studies. UNSa is the only public university in Salta, attracting students from across both urban centers and rural areas. First-year students are required to undergo a routine health check, which provides an opportunity for offering Chagas screening. While incoming students are the primary target population, other members of the university are also eligible to participate.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Member of the university community (e.g., student, faculty, administrative staff, or other personnel). * Aged 18 years or older. * Of any sex or gender. * Able and willing to provide informed consent. Exclusion Criteria: \- Prior confirmed diagnosis of Trypanosoma cruzi infection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chagas disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chagas disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chagas disease Chronic chagas disease Trypanosoma cruzi infection

Contacts and locations

Locations

  • Universidad Nacional de Salta

    Orán, Salta Province, 4530, Argentina

  • Universidad Nacional de Salta

    Salta, Salta Province, 4400, Argentina

More trials for these conditions

Other studies related to the condition(s) this trial covers.